Duke Receives Grant to Fund Development of Potential HIV Vaccine

Article

Duke University has received a grant of up to $2.9 million from the Bill & Melinda Gates Foundation to produce an HIV vaccine candidate that will be tested in humans.

The investigational vaccine is the product of recent research focused on designing HIV outer coat molecules that selectively bind to the right kind of antibodies to create a more lasting immune response.

We are grateful to the Bill & Melinda Gates Foundation to provide the funding for this important next step of our research, said principal investigator Barton Haynes, director of the Duke Human Vaccine Institute. Our strategy is to develop vaccines that bind to neutralizing antibodies and avoid inducing less effective, non-neutralizing antibodies that are frequently seen in natural infections and with previous vaccine candidates. This funding will help speed our progress.

Haynes said the vaccine candidate, a man-made lipid termed a liposome, is designed to mimic a virus particle. The synthetic virus-like particle will be made of lipids that are similar to those in the membrane of the virus itself, and will include a piece of the HIV outer envelope that binds to the sought-after neutralizing antibodies.

The liposome vaccine is a promising candidate because it both mimics the virus itself, and because it is inexpensive to produce, says Munir Alam, PhD, a professor of medicine and pathology at Duke who led the effort to develop the vaccine candidate.

The studies funded with this grant will be the first of several successive studies required in animal models and humans for the development of immunization regimens targeted at inducing broadly neutralizing antibodies, Haynes says. This step is precisely what is needed to speed the development of a successful vaccine.

The grant will cover three years, beginning with the formulation of the investigational immunogen, followed by animal studies and culminating in production of the vaccine for use in a phase one trial involving human participants.

Source: Duke Medicine

Related Videos
NFID Medical Director, Robert H. Hopkins, Jr., MD  (Photo courtesy by Evoke Kyne)
Shelley Summerlin-Long, MPH, MSW, BSN, RN, senior quality improvement leader, infection prevention, UNC Medical Center, Chapel Hill, North Carolina
Infection Control Today Infection Intel: Staying Ahead with Company updates and product Innovations.
An eye instrument holding an intraocular lens for cataract surgery. How to clean and sterilize it appropriately?   (Adobe Stock 417326809By Mohammed)
Christopher Reid, PhD  (Photo courtesy of Christopher Reid, PhD)
Paper with words antimicrobial resistance (AMR) and glasses.   (Adobe Stock 126570978 by Vitalii Vodolazskyi)
3D illustration: Candida auris   (Adobe Stock 635576411 By Niamh )
 MIS-C (Adobe Stock 350657530 by Bernard Chantal)
Set of white bottles with cleaning liquids on the white background. (Adobe Stock 6338071172112 by zolnierek)
Related Content